Corrigendum: Prediction of severe CRS and determination of biomarkers in B cell-acute lymphoblastic leukemia treated with CAR-T cells.

Wei, Zhenyu; Xu, Jiayu; Zhao, Chengkui; Zhang, Min; Xu, Nan; Kang, Liqing; Lou, Xiaoyan; Yu, Lei; Feng, Weixing

Wei, Zhenyu; Xu, Jiayu; Zhao, Chengkui; Zhang, Min; Xu, Nan; Kang, Liqing; Lou, Xiaoyan; Yu, Lei; Feng, Weixing.

Afiliação

Wei Z; Intelligent Systems Science and Engineering College, Harbin Engineering University, Harbin, China.
Xu J; Intelligent Systems Science and Engineering College, Harbin Engineering University, Harbin, China.
Zhao C; Intelligent Systems Science and Engineering College, Harbin Engineering University, Harbin, China.
Zhang M; Shanghai Unicar-Therapy BioMedicine Technology Co., Ltd, Shanghai, China.
Xu N; Intelligent Systems Science and Engineering College, Harbin Engineering University, Harbin, China.
Kang L; Shanghai Unicar-Therapy BioMedicine Technology Co., Ltd, Shanghai, China.
Lou X; School of Chemical and Molecular Engineering, East China Normal University, Shanghai, China.
Yu L; Shanghai Unicar-Therapy BioMedicine Technology Co., Ltd, Shanghai, China.
Feng W; School of Chemical and Molecular Engineering, East China Normal University, Shanghai, China.

Front Immunol ; 15: 1379325, 2024.

Article em En | MEDLINE | ID: mdl-38333207

ABSTRACT

ABSTRACT

[This corrects the article DOI 10.3389/fimmu.2023.1273507.].

Palavras-chave

CAR-T cell therapy; biomarker; cytokine release syndrome (CRS); decision tree; prediction

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Immunol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China País de publicação: CH / SUIZA / SUÍÇA / SWITZERLAND

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google